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The aim of the study was to determine whether use of fluorescence bronchoscopy improves
the detection of preinvasive neoplastic bronchial lesions. The data of all patients who
underwent fluorescence bronchoscopy and in whom bronchial biopsies were taken, were
analyzed. Most patients were at risk for preinvasive lesions. A total of 174 bronchoscopies
were performed in 95 patients. Of the 681 representative biopsies, 31 were found to be
moderate dysplastic, 39 were found to be severe dysplastic and 9 exhibited carcinoma
in situ. These 79 preinvasive lesions were found in 34 patients. The respective results of
fluorescence bronchoscopy in addition to conventional bronchoscopy and of conventional
bronchoscopy alone for detection of preinvasive lesions were: sensitivity 85% (67/79) and
59% (47]79); specificity 60% (351/581) and 85% (493/581); positive predictive values of
23% (67/297) and 35% (47/135); negative predictive values of 97% (3511363) and 94%
(493]525). A separate analysis of only the first bronchoscopy of each patient showed
similar results. Results of fluoresence bronchoscopy were better in the second part of the
patient group. We conclude that after a learning period fluorescence bronchoscopy can
increase the yield of finding preinvasive neoplastic lesions when used in addition to conven-
tional bronchoscopy.
Keywords: Early lung cancer, Fluorescence bronchoscopy, Intraepithelial neoplasia, LIFE,
Lung imaging fluorescence endoscope, Preinvasive neoplasia
INTRODUCTION
Squamous cell carcinoma of the bronchus is
thought to arise after a series of progressive histo-
logic changes in the bronchial epithelium [1].
These preinvasive neoplastic lesions are, in order
of increasing severity: basal cell hyperplasia, meta-
plasia, mild, moderate and severe dysplasia, and
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carcinoma in situ. When the bronchial mucosa is
illuminated by a blue light with a wavelength of
405-442nm, such as light from a Krypton ion
laser or a Helium-Cadmium laser, there is a pro-
gressive reduction in the green wavelength band
of the autofluorescence spectrum as the tissue
becomes more neoplastic [2,3]. Based on this dif-
ference in fluorescence intensity, the lung imaging
fluorescence endoscope (LIFE) system (Xillix
Technologies Corp; Richmond, BC, Canada) was
developed to detect preinvasive bronchial lesions
[4,5]. LIFE provides true fluorescence images in
real time. Normal tissue which fluoresces green,
can be distinguished from neoplastic tissue which
appears to be brown or brownish red in color
depending on the pathology grade. Experience
with the LIFE system has shown that it can
improve the detection rate of preinvasive bron-
chial lesions compared with conventional
bronchoscopy. Lam et al. [5] found the sensitivity
of LIFE to be twice the sensitivity of conventional
bronchoscopy for the detection of preinvasive
bronchial lesions. Fluorescence bronchoscopy
could therefore be clinically useful in detecting
and localizing early lung cancer, in staging the
extent of endobronchial spread of bronchial can-
cer and in detecting synchronous roentgenogra-
phically occult cancer. Early detection may
improve the prognosis of lung cancer patients,
since it was shown that early treatment as surgical
resection or bronchoscopic treatment for roent-
genographically occult intraluminal tumors gives
the best chance for cure [6-14]. We started using
the LIFE system in clinical practice in November
1995. The aim of this study was to determine
whether use of the LIFE system improves the
detection of preinvasive bronchial lesions. Prein-
vasive lesions were defined as lesions that were
scored by the pathologist as moderate dysplasia,
severe dysplasia or carcinoma in situ. These prein-
vasive lesions were considered clinically important
in the population at risk, and were considered to
be the interest of using a LIFE system for early
tumor detection.
MATERIALS AND METHODS
Bronchoscopy
All the patients from the Department of Pulmon-
ary Medicine of the University Hospital Vrije
Universiteit in Amsterdam who underwent a
LIFE bronchoscopy in the period from November
1995 to December 1997 and in whom bronchial
biopsies were taken were included in this study.
The results of 33 of these patients were reported
before [15]. In these 33 patients the modality of
the initial bronchoscopy to be performed, conven-
tional bronchoscopy or LIFE, was detemined by
randomization. Indications for LIFE broncho-
scopy in most patients of the present study were:
suspected lung cancer, staging of newly diagnosed
lung cancer or follow-up of lung or head and neck
cancer. All bronchoscopic procedures were per-
formed by the same bronchoscopist (TS). Stan-
dard bronchoscopy procedure was followed.
Local anesthesia with lidocaine 2% spraying was
administered to all patients. In the decubitus posi-
tion, the bronchoscope (Olympus BF-20D) was
introduced transorally. The fiberoptic broncho-
scope was coupled to either the conventional or
the LIFE video camera and bronchoscopy was
performed. Careful bronchoscopy is obligatory to
prevent unnecessary mucosal contact, as hemor-
rhagic bruising may undermine imaging. Digitized
images were videotaped and frozen images of
abnormal or suspicious lesions were captured. All
locations were documented. After switching the
camera, bronchoscopic examination was repeated
in the same manner using the alternate device. All
abnormal and suspicious lesions were separately
biopsied, using a new biopsy forceps for each
location to prevent contamination. In all cases at
least one biopsy was taken of an area considered
not suspicious during both LIFE and conven-
tional bronchoscopy. Abnormalities detected by
the LIFE were biopsied using the LIFE camera to
ensure the exact spot, unless images were too
blurred because of hemorrhagic bruising of theRESULTS OF FLUORESCENCE BRONCHOSCOPY 79
mucosa during manipulation. Abnormalities
detected only during conventional bronchoscopy
were subsequently biopsied.
Histological Examination
The biopsies were processed in a routine fashion.
After fixation for at least 24h in 4% buffered
formalin, the tissue was blocked in paraffin and
4gm slides were mounted on glass and stained
with hematoxylin and eosin using standard proce-
dure. The pathologists reported the results of
microscopy of all specimens in separate jars, by
indicating them to be: unsatisfactory, normal,
inflammation, hyperplasia, mild dysplasia, moder-
ate dysplasia, severe dysplasia, carcinoma in situ,
and carcinoma.
Analysis
The results of the histologic examination were
compared with the results of the visual assessment
using the conventional and the LIFE cameras.
Sensitivity, specificity, positive and negative pre-
dictive values for detection of the total number
of moderate dysplasias, severe dysplasias and
carcinomas in situ were calculated. The relative
sensitivity, or the ratio of the sensitivity of con-
ventional bronchoscopy combined with LIFE, as
compared with conventional bronchoscopy alone,
along with the 95% confidence interval (CI), was
calculated to evaluate the contribution of fluores-
cence examination to detect preinvasive lesions.
The results of all bronchoscopies using the LIFE
system were analyzed. In a subgroup of patients
several LIFE bronchoscopies were done. Because
patient selection may influence the results, a sepa-
rate analysis was performed using only the first
bronchoscopy data of each patient. This second
analysis was also used to examine if there is a
learning effect in using the LIFE system. We
therefore compared the results of the first 48
patients with the results obtained in the next 47
consecutive patients.
RESULTS
Patients demographics and bronchoscopy data are
shown in Table I. A total of 174 bronchoscopies
were performed in 95 patients. All procedures
were completed under local anesthesia and no
complications were observed during or after
bronchoscopic examination. The median duration
of the additional LIFE examination was 15 min
(range: 5-25 min). Of the total number of biopsies
taken, 92% (681/742) was judged by the patho-
logists to be satisfactory, enabling adequate assess-
ment of the morphology. Three-hundred-and-two
of these 681 biopsies were taken based on suspi-
cious findings during LIFE bronchoscopy. One-
hundred-and-fourty of these 302 biopsies were
TABLE Patient demographics and bronchoscopy data
All bronchoscopies First bronchoscopies
Number of patients
Male/female
Median age at bronchoscopy (range)
Total number of bronchoscopies
Median number of bronchoscopies (range) per patient
Indications for bronchoscopy (no. (%))
Suspected or known lung cancer
Follow-up treated lung or head and neck cancer
Other
Total number of biopsies
Median number of biopsies per bronchoscopy (range)
95 95
75/20 75/20
65 (32-82) 64 (32-82)
174 95
(1-9) 1(1)
85 (49) 64 (68)
82 (47) 25 (26)
7 (4) 6 (6)
742 358
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considered suspicious as well during conventional
bronchoscopy. Sixteen biopsies were taken from
areas considered suspicious during conventional
bronchoscopy which were considered not suspi-
cious by LIFE bronchoscopy. Overall 318 biopsies
were taken from suspicious areas based on endo-
scopic findings (Table II). Of the 681 representa-
tive specimens, 31 were found to be moderate
dysplastic, 39 were found to be severe dysplastic, 9
exhibited carcinoma in situ and 21 showed carci-
noma. One moderate dysplasia, 2 severe dyspla-
sias, carcinoma in situ and 2 carcinomas were
seen only using the conventional bronchoscope
and were missed with the LIFE system. Eleven
moderate dysplasias, 8 severe dysplasias and
carcinoma in situ were seen only using the LIFE.
Twelve moderate dysplasias were missed by both
modalities (Table II). The 79 preinvasive lesions
were found in 34 patients (female/male 8/26) and
the 21 carcinomas were found in 16 patients
(female/male 2/14). A total of 12 preinvasive
lesions were found in 6 of the latter 16 patients.
The respective results of conventional broncho-
scopy combined with LIFE and of conventional
bronchoscopy alone for detection of the combined
moderate dysplasias, severe dysplasias and carci-
nomas in situ were: sensitivity 85% (67/79) and
59% (47/79); specificity 60% (351/581) and 85%
(493/581); positive predictive values of 23% (67/
297) and 35% (47/135); negative predictive values
of 97% (351/363) and 94% (493/525). These
results are shown in Table IV. The relative sensi-
tivity of conventional bronchoscopy combined
with LIFE vs conventional bronchoscopy alone
was 1.43 (95% CI 1.16-1.75).
A separate analysis of the results of only the
first bronchoscopies showed that 94% (337/358)
of the biopsies taken were judged to be satisfac-
tory for histological examination. Fourty preinva-
sive lesions were found in 25 patients (female/male
5/20) and 16 carcinomas were found in 13 patients
(female/male 1/12). A total of 3 preinvasive lesions
were found in 3 of these 13 patients. Two of these
3 preinvasive lesions were found in other bronchi
TABLE II Data of all bronchoscopies and results of histologic examination
Bronchoscopic assessment No. of specimens
Lesions satisfactory Moderate Severe Carcinoma Carcinoma
for histological examination dysplasia dysplasia in situ
Suspicious by LIFE and CB
Suspicious by LIFE, not by CB
Suspicious by CB, not by LIFE
Not suspicious by LIFE and CB
Total
140 7 29 7 19
162 11 8 0
16 2 2
363 12 0 0 0
681 31 39 9 21
CB conventional bronchoscopy.
TABLE III Data of first bronchoscopies only and results of histologic examination
Bronchoscopic assessment No. of specimens
Lesions satisfactory Moderate Severe Carcinoma Carcinoma
for histological examination dysplasia dysplasia in situ
Suspicious by LIFE, and CB
Suspicious by LIFE, not by CB
Suspicious by CB, not by LIFE
Not suspicious by LIFE and CB
Total
73 4 16 6 14
60 3 2 0
l0 0 2
194 6 0 0 0
337 13 19 8 16
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TABLE IV Results of conventional bronchoscopy and LIFE and of the combined modalities in detecting preinvasive lesions,
All bronchoscopies included in analysis
CB LIFE CB/LIFE
% No. % No. % No.
Sensitivity 59 47/79 80 63/79 85 67/79
Specificity 85 493/581 62 361/581 60 351/581
Positive predictive value 35 47/135 22 63/283 23 67/297
Negative predictive value 94 493/525 96 361/377 97 351/363
aBiopsies showing cancer not included in analysis; CB conventional bronchoscopy.
TABLE V Results of conventional bronchoscopy and LIFE and of the combined modalities in detecting preinvasive lesions,
Only first bronchoscopies included in analysis
CB LIFE CB/LIFE
% No. % No. % No.
Sensitivity 70 28/40 80 32/40 85 34/40
Specificity 86 242/281 69 194/281 67 188/281
Positive predictive value 42 28/67 27 32/119 27 34/127
Negative predictive value 95 242/254 96 194/202 97 188/194
aBiopsies showing cancer not included in analysis; CB conventional bronchoscopy.
TABLE VI Results of LIFE bronchoscopy in detecting preinvasive lesions
Patients 1-48 Patients 49-95
% No. % No.
Sensitivity 67 8/12 86
Specificity 67 82/123 71
Positive predictive value 16 8/49 34
Negative predictive value 95 82/86 97
24/28
/58
24/70
112/116
aOnly first biopsies included in analysis and biopsies showing canoer excluded.
than the one where the carcinoma was localized.
The bronchoscopy data, the results of the histo-
logic examination and the performance of conven-
tional bronchoscopy and LIFE in detecting
preinvasive lesions are shown in Tables III and V.
The relative sensitivity of conventional broncho-
scopy combined with LIFE vs conventional
bronchoscopy alone was 1.14 (95% CI 0.89-
1.48). The results are comparable to those of all
bronchoscopies. There was a trend that conven-
tional bronchoscopy combined with LIFE was
more sensitive in detecting preinvasive changes in
the bronchial mucosa than conventional broncho-
scopy alone. However, at cost of a lower sensitiv-
ity and positive predictive value. In Table VI the
performance of LIFE in detecting preinvasive
lesions in the first half of the patient group is
compared with the results in the second half. As
can be seen from the table there seems to be a
learning effect using the LIFE system. Sensitivity,
specificity, positive predictive value and negative
predictive value all were higher in the second half
of the patient group.
DISCUSSION
Finding more early stage cancer lesions in the
central airways which can be treated with curative82 B.J.W. VENMANS et al.
intent using currently available treatment modal-
ities such as photodynamic therapy or electrocau-
tery may improve the poor prognosis of patients
with lung cancer [9-14]. Efforts have been made
in applying conventional fiberoptic bronchoscopy
to detect and localize early stage lung cancer [16-
18]. Even in patients with positive sputum cytol-
ogy repeated bronchoscopic examinations were
necessary and this was despite the fact that only a
proportion of the lesions were preinvasive. There-
fore the routine use of conventional fiberoptic
bronchoscopy seems impractical for screening
high risk individuals among the high numbers of
smokers with COPD [19], those with a previous
history of curatively treated head and neck cancer
[20] and those at risk for multiple or subsequent
lung cancers [21]. The LIFE system has been
developed to detect and localize preinvasive
lesions [4,5]. In 53 patients with known or
suspected bronchogenic carcinoma and 41 volun-
teers, the sensitivity of conventional bronchoscopy
in detecting moderate/severe dysplasia and carci-
noma in situ was 48.4% with a specificity of 94%.
With fluorescence imaging the sensitivity was
72.5% with the same specificity [4]. In another
study by Lam et al. the proportion of biopsy
proven moderate/severe dysplasia, and carcinoma
in situ detected by conventional bronchoscopy
alone was 38.5% and 40%, respectively. With
addition of LIFE examination, the detection rate
was 73.1% and 91.4%, respectively. The specifi-
city of conventional bronchoscopy was 91.1%.
With fluorescence bronchoscopy, the specificity
was 86.7% [5]. In the present study the sensitiv-
ities of the LIFE system in detecting moderate/
severe dysplasia and carcinoma in situ were 80%.
When LIFE was added to conventional broncho-
scopy the sensitivities improved to 85%. These
results are comparable to those mentioned above.
In recent studies sensitivities of 90% and 67%
in detecting (pre)invasive lesions were reported
[22,23]. However, the specificities when using the
LIFE system were lower in the present study (60-
69%). This resulted in low positive predictive
values for detection of preinvasive lesions when
LIFE was added to conventional bronchoscopy
(23% and 27%). However, in the only other study
reporting a positive predictive value this was
found to be 23% [23]. The negative predictive
values when LIFE was added to conventional
bronchoscopy were very high (97%) in the present
study. Lam et al. recently reported a negative
predictive value of 89% [23]. The sensitivities of
conventional bronchoscopy were higher in the
present study (59% and 70%), with similar
specificities. Yokomise et al. also found a high
sensitivity (65%) of conventional bronchoscopy.
However, biopsies showing cancer were included
in their analysis [22]. Dysplasia and carcinoma
in situ are difficult to detect during a standard
fiberoptic bronchoscopic examination, because
these lesions are superficial and minute in size
[21,24]. However, subtle changes may be seen such
as increased redness, changes in vascularization,
local swelling, relatively thickened mucosa, loss of
luster etc. [25], as can be learned by experience
while performing careful bronchoscopic examina-
tion of the entire tracheobronchial tree. Some pre-
invasive lesions and even two carcinomas were
seen by conventional bronchoscopy but were mis-
sed by LIFE. This study therefore confirms that
fluorescence bronchoscopy cannot replace con-
ventional bronchoscopy but should be performed
in addition to it [23]. Several preinvasive lesions
were missed by both conventional bronchoscopy
and LIFE. However, histologic examination of
these lesions only showed moderate dysplasias.
So only the lesions with the lowest degree of pre-
invasive changes, that were considered to be the
interest of using the LIFE system in this study,
were missed. The reason of the failure of LIFE to
localize some (pre)invasive lesions is not clear.
Moreover the meaning of suspicious LIFE find-
ings with negative histology also is unknown.
Whether these lesions represent very early changes
at the molecular level is unclear. In biopsies taken
by others, using the LIFE system, molecular
genetic changes such as cumulative gene losses in
the progression of preinvasive epithelial lesions
have been found [26-28]. The fluorescence patternRESULTS OF FLUORESCENCE BRONCHOSCOPY 83
of the bronchial mucosa may therefore reflect [4]
molecular genetic changes which are beyond the
threshold of the macroscopic and microscopic
[5]
abilities of the bronchoscopist and the pathologist.
By using current technique and histological criter-
ia as the golden standard for diagnosing preinva- [6]
sive lesions, the clinical impact of molecular
genetic changes and its relation to tissue auto- [7]
fluorescence remains elusive. A subgroup of
patients underwent several LIFE bronchoscopies. [8]
To exclude that patient selection bias may influ-
ence the results, a separate analysis was performed
[9]
using only the first bronchoscopy of each patient.
The results of this analysis were comparable to
those of all the bronchoscopies. The number of [10]
preinvasive lesions found with LIFE was higher
and the best results were obtained when both [111
modalities were combined. Both analyses showed
that specificity and positive predictive were lower
when LIFE was used and that a high sensitivity [12]
can be obtained by conventional bronchoscopy
alone. To study if" there was a learning effect in
using the LIFE system the results of the first
bronchoscopies of the first half of the patient [13]
group were compared with the results obtained in
the second half. Sensitivity, specificity, positive [141
predictive value and negative predictive value all
were higher in the second half of the patient
group. This indicates a learning effect in using the
LIFE system. We conclude that fluorescence [15]
bronchoscopy can be performed safely and that
after a learning period it can increase the yield of
finding preinvasive neoplastic lesions when used [16]
in addition to conventional bronchoscopy.
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